- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High fibrinogen-to-albumin ratio powerful predictor of adverse outcomes in CAD patients
An original article was published in the Journal of Cardiovascular Translational Research on June 22. "The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort" by Hou et al. and colleagues has discussed the association of FAR or fibrinogen-to-albumin ratio (FAR) with the clinical outcomes of coronary artery disease (CAD).
Patients with CAD history were from a prospective cohort which recruited 15,250 patients admitted to the First Affiliated Hospital of Xinjiang Medical University between December 2016 and October 2021.
Fourteen thousand nine hundred ninety-four patients enrolled were divided into two groups using ROC curve analysis. The primary endpoints were all-cause mortality (ACM) and cardiac mortality (CM), and secondary endpoints were major adverse cardiovascular events (MACEs), major adverse cardiac and cerebrovascular events (MACCEs), and non-fatal myocardial infarction (NFMI).
The study summary draws the following considerations:
- There were 10,076 participants in the low-FAR group and 4918 in the high-FAR group.
- Researchers compared the incidence of outcomes between the two groups.
- High-FAR group exhibited a higher incidence of ACM (5.3% vs 1.9%), CM (3.9% vs 1.4%), MACEs (9.8% vs 6.7%), MACCEs (10.4% vs 7.6%), and NFMI (2.3% vs 1.3%) when compared to the low-FAR group.
- The risk in the high-FAR group was increased by 2.182 fold in ACM, 2.116 fold in CM, 1.327 fold in MACEs, 1.280 fold in MACCEs and 1.791 fold in NFMI to the low-FAR group.
They concluded by saying, “High FAR group is an independent and powerful predictor of adverse outcomes in Coronary Artery Disease patients.”
Further reading:
https://link.springer.com/article/10.1007/s12265-023-10402-9
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751